Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16962835rdf:typepubmed:Citationlld:pubmed
pubmed-article:16962835lifeskim:mentionsumls-concept:C0327472lld:lifeskim
pubmed-article:16962835lifeskim:mentionsumls-concept:C0001044lld:lifeskim
pubmed-article:16962835lifeskim:mentionsumls-concept:C0014898lld:lifeskim
pubmed-article:16962835lifeskim:mentionsumls-concept:C0596988lld:lifeskim
pubmed-article:16962835lifeskim:mentionsumls-concept:C1149632lld:lifeskim
pubmed-article:16962835lifeskim:mentionsumls-concept:C1510827lld:lifeskim
pubmed-article:16962835lifeskim:mentionsumls-concept:C0205251lld:lifeskim
pubmed-article:16962835pubmed:issue9lld:pubmed
pubmed-article:16962835pubmed:dateCreated2006-9-18lld:pubmed
pubmed-article:16962835pubmed:abstractTextEnzymes hydrolysing highly toxic organophosphate esters (OPs) are promising alternatives to pharmacological countermeasures against OPs poisoning. Bungarus fasciatus acetylcholinesterase (BfAChE) was engineered to acquire organophosphate hydrolase (OPase) activity by reproducing the features of the human butyrylcholinesterase G117H mutant, the first mutant designed to hydrolyse OPs. The modification consisted of a triple mutation on the (122)GFYS(125) peptide segment, resulting in (122)HFQT(125). This substitution introduced a nucleophilic histidine above the oxyanion hole, and made space in that region. The mutant did not show inhibition by excess acetylthiocholine up to 80 mM. The k(cat)/K(m) ratio with acetylthiocholine was 4 orders of magnitude lower than that of wild-type AChE. Interestingly, due to low affinity, the G122H/Y124Q/S125T mutant was resistant to sub-millimolar concentrations of OPs. Moreover, it had hydrolysing activity with paraoxon, echothiophate, and diisopropyl phosphofluoridate (DFP). DFP was characterised as a slow-binding substrate. This mutant is the first mutant of AChE capable of hydrolysing organophosphates. However, the overall OPase efficiency was greatly decreased compared to G117H butyrylcholinesterase.lld:pubmed
pubmed-article:16962835pubmed:languageenglld:pubmed
pubmed-article:16962835pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16962835pubmed:citationSubsetIMlld:pubmed
pubmed-article:16962835pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16962835pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16962835pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16962835pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16962835pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16962835pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16962835pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16962835pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16962835pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16962835pubmed:statusMEDLINElld:pubmed
pubmed-article:16962835pubmed:monthSeplld:pubmed
pubmed-article:16962835pubmed:issn0006-3002lld:pubmed
pubmed-article:16962835pubmed:authorpubmed-author:MassonPatrick...lld:pubmed
pubmed-article:16962835pubmed:authorpubmed-author:NachonFlorian...lld:pubmed
pubmed-article:16962835pubmed:authorpubmed-author:LockridgeOksa...lld:pubmed
pubmed-article:16962835pubmed:authorpubmed-author:FromentMarie-...lld:pubmed
pubmed-article:16962835pubmed:authorpubmed-author:SchopferLawre...lld:pubmed
pubmed-article:16962835pubmed:authorpubmed-author:PoyotThomasTlld:pubmed
pubmed-article:16962835pubmed:authorpubmed-author:LoiodiceMélan...lld:pubmed
pubmed-article:16962835pubmed:authorpubmed-author:WieselerStacy...lld:pubmed
pubmed-article:16962835pubmed:issnTypePrintlld:pubmed
pubmed-article:16962835pubmed:volume1764lld:pubmed
pubmed-article:16962835pubmed:ownerNLMlld:pubmed
pubmed-article:16962835pubmed:authorsCompleteYlld:pubmed
pubmed-article:16962835pubmed:pagination1470-8lld:pubmed
pubmed-article:16962835pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:16962835pubmed:meshHeadingpubmed-meshheading:16962835...lld:pubmed
pubmed-article:16962835pubmed:meshHeadingpubmed-meshheading:16962835...lld:pubmed
pubmed-article:16962835pubmed:meshHeadingpubmed-meshheading:16962835...lld:pubmed
pubmed-article:16962835pubmed:meshHeadingpubmed-meshheading:16962835...lld:pubmed
pubmed-article:16962835pubmed:meshHeadingpubmed-meshheading:16962835...lld:pubmed
pubmed-article:16962835pubmed:meshHeadingpubmed-meshheading:16962835...lld:pubmed
pubmed-article:16962835pubmed:meshHeadingpubmed-meshheading:16962835...lld:pubmed
pubmed-article:16962835pubmed:meshHeadingpubmed-meshheading:16962835...lld:pubmed
pubmed-article:16962835pubmed:meshHeadingpubmed-meshheading:16962835...lld:pubmed
pubmed-article:16962835pubmed:meshHeadingpubmed-meshheading:16962835...lld:pubmed
pubmed-article:16962835pubmed:meshHeadingpubmed-meshheading:16962835...lld:pubmed
pubmed-article:16962835pubmed:meshHeadingpubmed-meshheading:16962835...lld:pubmed
pubmed-article:16962835pubmed:year2006lld:pubmed
pubmed-article:16962835pubmed:articleTitleMutant of Bungarus fasciatus acetylcholinesterase with low affinity and low hydrolase activity toward organophosphorus esters.lld:pubmed
pubmed-article:16962835pubmed:affiliationDépartement de Toxicologie, Centre de Recherches du Service de Santé des Armées, BP 87, 38702 La Tronche Cedex, France. tpoyot@crssa.netlld:pubmed
pubmed-article:16962835pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16962835pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16962835lld:pubmed